Does BENDAMUSTINE Cause Neoplasm progression? 257 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 257 reports of Neoplasm progression have been filed in association with BENDAMUSTINE (VIVIMUSTA). This represents 1.3% of all adverse event reports for BENDAMUSTINE.
257
Reports of Neoplasm progression with BENDAMUSTINE
1.3%
of all BENDAMUSTINE reports
100
Deaths
82
Hospitalizations
How Dangerous Is Neoplasm progression From BENDAMUSTINE?
Of the 257 reports, 100 (38.9%) resulted in death, 82 (31.9%) required hospitalization, and 4 (1.6%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENDAMUSTINE. However, 257 reports have been filed with the FAERS database.
What Other Side Effects Does BENDAMUSTINE Cause?
Off label use (2,578)
Disease progression (2,456)
Pyrexia (1,322)
Neutropenia (1,256)
Drug ineffective (1,135)
Febrile neutropenia (1,005)
Pneumonia (975)
Thrombocytopenia (967)
Covid-19 (892)
Anaemia (817)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which BENDAMUSTINE Alternatives Have Lower Neoplasm progression Risk?
BENDAMUSTINE vs BENDROFLUMETHIAZIDE
BENDAMUSTINE vs BENIDIPINE
BENDAMUSTINE vs BENLYSTA
BENDAMUSTINE vs BENRALIZUMAB
BENDAMUSTINE vs BENSERAZIDE